Investment Snapshot
- P/B of 136.74 — trading above book value
- Piotroski F-Score 5/9 — moderate financial health
- Loss-making — negative ROE of -923.6%
- Revenue growing at 35% annually
SANUWAVE Health, Inc. - Common Stock (SNWV) is a Healthcare company operating in Medical Devices, listed on the NASDAQ , with a market capitalisation of $221 million . Key value metrics: P/B ratio 136.74, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
SANUWAVE Health, Inc. - Common Stock — Fundamental Analysis Summary
On financial health, SNWV shows a moderate Piotroski F-Score of 5/9, and negative return on equity of -923.6% (sector average: -19.8%), and high leverage with a debt-to-equity ratio of 13.52.
StockPik's composite Value Score for SNWV is 29/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
SNWV reports a high gross margin of 77.7% (sector average: 33.5%) and a solid operating margin of 15.6%.
SNWV shows revenue growing at 35% year-over-year, with earnings growing at 138%.